BofA/Merrill Lynch Downgrades West Pharmaceutical (WST) to Underperform

April 25, 2018 6:03 AM

BofA/Merrill Lynch downgraded West Pharmaceutical (NYSE: WST) from Neutral to Underperform with a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found